Pharma reputation falls again, notching double-digit downturn over past year in US — survey
The pharma industry’s reputation continues to slip in the US as consumers pack away its pandemic hero status. The newest survey from The Harris Poll shows the industry at a 45% positive rating last month, down 10 percentage points from the same time last year.
While 45% is still above the just 32% pre-pandemic low that the industry held at beginning of 2020, it’s also notably lower than the 62% high point in February 2021. The 10-percentage point pharma drop since last fall is also the biggest decrease across all the industries that Harris Poll tracks, said managing director Rob Jekielek.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,900+ biopharma pros reading Endpoints daily — and it's free.